Diabetes

A rising healthcare concern, a growing therapeutic space

Diabetes is a significant healthcare concern in Malaysia and its threat continues to grow among the population. Since 2016 Duopharma Biotech has supplied over 100 million cartridges of insulin to people with Diabetes in Malaysia.

1 in 6 adults

in Malaysia have diabetes, equivalent to 15.6% of the adult population.

National Health and Morbidity Survey (NHMS) 2023¹

Diabetes Rising

Data from the National Health and Morbidity Survey over the years shows a steadily rising prevalence of diabetes – among those diagnosed with the disease as well as undiagnosed Malaysians who have raised blood glucose.²

Patients Enrolled in Registry

Male

42.92%

Female

57.08%

patients with diabetes

1.95 million

As of 2023, there was a total of 1,946,133 patients enrolled in the National Diabetes Registry, with 870,771 being active patients who had visited a health clinic at least once in the past year. ¹

type 2 diabetes

>99%

Almost all (99.48%) registered patients had been diagnosed with Type 2 Diabetes. The majority were between 65-69 years old (16.10%) and the mean age at diagnosis was 65 years old.

co-morbidities

Risk

The vast majority of patients also had common co-morbidities, particularly hypertension (81.10%) and dyslipidaemia (78.39%).

ethical

Pharmaceuticals

Most patients were on common oral anti-diabetic drugs such as metformin (85.57%) and sulphonylureas (42.40%), while 22.60% were treated with insulin.

Our Therapies

There is a clear demand for effective medicines that can help Malaysians with diabetes control their disease for better quality of life. Among our portfolio of classic and specialty pharmaceutical drugs for the domestic and international market are generic drugs and biosimilar products to treat prevalent diseases such as diabetes.

Our specialty portfolio includes biosimilar insulin therapies for diabetes including Insugen and Basalog One.

INSUPen Pro reusable injectable pen devices are designed for use exclusively with the Insugen range of insulins.